Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Sagent Pharmaceuticals, Inc.Listing unverified | Sell | $31.2K | SEC | ||
Sagent Pharmaceuticals, Inc.Listing unverified | Sell | $230.4 | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $36.8K | conv 41ClusterFirst in 12mo | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $5M | conv 54ClusterFirst in 12mo | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC |